Physician
Cerone, Dana
Cerone, Dana was paid $301K by Medicaid between Aug 2018 and Oct 2024, across 16 billing codes. Its largest line is 87636, Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B — 37% of everything it billed.
33Billing provider infoCERONE, DANA
PALMER, MA 01069
PALMER, MA 01069
33aNPI1407057029assigned 05/30/2007
33bProvider typeInternal Medicine Physician
28Total paid$301K
24GClaims3,547
24DCodes billed16
24AFirst – last monthAug 2018 – Oct 2024
Compared with peers
Next to other Internal Medicine Physician providers in Massachusetts
Rank by total paid#117 of 1,270
Median peer was paid$8K
This provider vs. median36×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13 | $1K | |
| 2019 | 104 | $6K | |
| 2020 | 365 | $20K | |
| 2021 | 1,425 | $136K | |
| 2022 | 961 | $85K | |
| 2023 | 585 | $44K | |
| 2024incomplete | 94 | $7K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 37% | 802 | 762 | $113K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 561 | 537 | $47K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 11% | 238 | 233 | $34K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 9.3% | 240 | 240 | $28K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.2% | 497 | 475 | $25K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 7.2% | 285 | 285 | $22K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 3.4% | 115 | 113 | $10K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.4% | 267 | 263 | $7K |
| 87631 | 1.3% | 52 | 50 | $4K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.1% | 215 | 201 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.0% | 59 | 52 | $3K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 106 | 98 | $2K |
4 more codes
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 34 | $2K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 37 | $868.27 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 25 | $224.45 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 14 | $165.34 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.